Azitra (AZTR) Preferred Dividend Payments (2022 - 2023)
Azitra (AZTR) posted Preferred Dividend Payments of $643267.0 for Q2 2023, down 9.66% on a QoQ basis from $712080.0 in Q1 2023, and down 7.08% year-over-year from $692246.0 in Q2 2022.
Azitra (AZTR) Preferred Dividend Payments (2022 - 2023) Analysis & Trends
Azitra's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $643267.0 for Q2 2023.
- Quarterly Preferred Dividend Payments fell 7.08% year-over-year to $643267.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $643267.0 (down 76.93% YoY) and the FY2023 annual result came in at $1.4 million, down 51.05% from the prior year.
- Preferred Dividend Payments was $643267.0 for Q2 2023 at Azitra, down from $712080.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $712080.0 in Q1 2023 and bottomed at $643267.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 472.98 Bn | 468.19 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.73 Bn | 116.48 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.59 Bn | 62.84 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.67 Bn | 49.49 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 37.96 Bn | 34.95 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.08 Bn | 36.08 Bn | - | - |
| 10 | Azitra | 2.07 Mn | 2.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 643,267.00 |
| Mar 31, 2023 | 712,080.00 |
| Dec 31, 2022 | 692,247.00 |
| Sep 30, 2022 | 692,246.00 |
| Jun 30, 2022 | 692,246.00 |